Opinion: Publish Negative Results

Non-confirmatory or “negative” results are not worthless.

Written byBjorn R Olsen, Gabriella Anderson, and Haiko Sprott
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

FLICKR, JHRITZHypothesis-driven research is at the heart of scientific endeavor, and it is often the positive, confirmatory data that get the most attention and guide further research. But many studies produce non-confirmatory data—observations that refute current ideas and carefully constructed hypotheses. And it can be argued that these “negative data,” far from having little value in science, are actually an integral part of scientific progress that deserve more attention.

At first glance, this may seem a little nonsensical; after all, how can non-confirmatory results help science to progress when they fail to substantiate anything? But in fact, in a philosophical sense, only negative data resulting in rejection of a hypothesis represent real progress; positive data in support of the hypothesis cannot exclude the possibility that it may be rejected by future experiments. As philosopher of science Karl Popper stated in 1963: “Every refutation should be regarded as a great success; not merely a success of the scientist who refuted the theory, but also of the scientist who created the refuted theory and who thus in the first instance suggested, if only indirectly, the refuting experiment.”

On a more practical level, Journal of Negative Results ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies